Protein markers for the prognosis of breast cancer progression
US-2024230651-A1 · Jul 11, 2024 · US
US10585104B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10585104-B2 |
| Application number | US-201615270440-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 20, 2016 |
| Priority date | Apr 7, 2009 |
| Publication date | Mar 10, 2020 |
| Grant date | Mar 10, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The production and use of semiconducting nanopost arrays made by nanofabrication is described herein. These nanopost arrays (NAPA) provide improved laser ionization yields and controllable fragmentation with switching or modulation capabilities for mass spectrometric detection and identification of samples deposited on them.
Opening claim text (preview).
What is claimed is: 1. A process for making a nanopost array and sample combination for mass spectrometry analysis of the sample, comprising the steps of: generating by computer aided design a nanopost array mask pattern arrangement having a nanopost diameter of about 50 rim to about 800 nm and a periodicity of from about 100 nm to about 1600 nm; writing said mask pattern onto a substrate comprising silicon or semiconductor material, to produce processed areas that are covered with columnar structures having said diameter and said periodicity; developing said columnar structures to produce columnar structures comprising a height of about 100 nm to about 2000 nm; and depositing the sample on the columnar structures, wherein the sample is selected from the group consisting of pharmaceuticals, dyes; explosives, narcotics, polymers, single cells, small cell populations, cell cultures, tissue samples, and biomolecules. 2. The process of claim 1 , wherein the sample is adsorbed onto the columnar structures. 3. The process of claim 1 , wherein said array adapted to be in cooperative association with a laser having a specific wavelength wherein the periodicity of the nanopost is equal to the specific wavelength of the laser. 4. The process of claim 1 , wherein the sample is further selected from the group consisting of pharmaceuticals, dyes, explosives or explosive residues, narcotics, polymers, biomolecules, chemical warfare agents and their signatures, peptides, metabolites, lipids, oligosaccharides, proteins and other biomolecules, synthetic organics, drugs, and toxic chemicals. 5. The process of claim 1 , wherein the sample is microorganisms selected from the group consisting of unicellular eukaryotes, prokaryotes and viruses.
of solid biological material, e.g. tissue samples, cell cultures (tissue in vivo A61B5/00; cell suspensions G01N33/48735) · CPC title
Methods of protein analysis involving laser desorption ionisation mass spectrometry · CPC title
for laser desorption, e.g. matrix-assisted laser desorption/ionisation [MALDI] plates or surface enhanced laser desorption/ionisation [SELDI] plates · CPC title
Step by step routines describing the use of the apparatus (H01J49/0081 takes precedence) · CPC title
PV systems with concentrators · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.